Ossur hf
OTC:OSSUY
Relative Value
There is not enough data to reliably calculate the relative value of OSSUY.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
OSSUY Competitors Multiples
Ossur hf Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IS |
O
|
Ossur hf
OTC:OSSUY
|
11.3B USD | 2.2 | 31.2 | 16.4 | 24.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
193.5B USD | 4.4 | 29.7 | 17 | 23.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.3B USD | 17.1 | 60.4 | 45.8 | 56.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
135.2B USD | 5.4 | 41.4 | 21.1 | 25.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
114.1B USD | 3.2 | 24.7 | 13.6 | 19.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.1B USD | 5.3 | 36.6 | 21.5 | 28.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.7B EUR | 1.9 | 20.6 | 11.5 | 16.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD | 8.1 | 45.7 | 25.2 | 27.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47.2B USD | 11 | 44.6 | 31.6 | 35 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46.2B USD | 2.1 | 26.4 | 10.3 | 17.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
34B USD | 6.3 | 23 | 16.1 | 17.9 |